Mammary tumor cells derived from Mgat5−/− mice displayed reduced GAL-3 binding to TGF-βRII, demonstrating that this lectin can form multivalent complexes with TGF-βRII on the cell surface, thus preventing receptor endocytosis through N-glycan-dependent mechanisms (134). Here, LGALS3 is linked to breast cancer.